Immunology

Possible approach discovered for treating multiple sclerosis

Around 2.5 million people are affected by the autoimmune disease multiple sclerosis (MS), the most common central nervous system disease among young adults. There are around 12,500 MS sufferers in Austria and 400 new cases ...

Oncology & Cancer

Farydak approved for multiple myeloma

(HealthDay)—Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma, a cancer of the blood.

page 2 from 4